Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A in Reperfused Acute Myocardial Infarction
NCT01650662Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jan 2012
- Primary completion
- Oct 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in ST elevation myocardial infarction (STEMI), sponsored by Mario Negri Institute for Pharmacological Research. Started Jan 2012; status: completed.
02
Drugs
cyclosporine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01650662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650662.